ABSTRACT: Nam·e sl,matosrntin ts founJ throughout the gastromtesunal tract and has a wide \'artery oi hiolog1cal actions. Nevcrthell•ss, its short b1ol,)g1cal half-life and limitt·d sw bility necessitate tts u se, ta continuous parenteral infusion ar:d, thus, ltmm tts chcrarwuttc usefulness The development of long actrng sommost·ttin ,rnalogues h ave lcaJ to a rc-cxaminatton of the thcrapeutk useful-O('ss of somatosrattn in gastrointcstin,11 discast' Somatostntin analogues appear most hcnefic1al tn prcvcn ttn g symptoms assrn:tated with neurocndocnnc tumours. In aJditton, case controllt·d studies exist to d emonstrate somatostattn analogue cffcctn·encss m treatment of gastrrnntcstinal hemnrrhagt.
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1erradl'tapepttde tuund thmugh· ,,u1 dw gastrom u•,1111,11 tr:t( l ,Hid pnn· < rt'.1, m 1wrn· l·ndml!, ,111J muco,.11 ncur11endt1tr1111· , ell, ( 1-'i ) . Somato,tattn is lt1un,l 1n tlw higlw,t n11Kt't1lrat1011 m gas111c tundus .md .1111 rum, pancrt·as ,ind d tll 1dcnu m m dent'iisi ng n 1nl'l'r1tratt0ns frt,m pn1x1m,1l to distal small 111test1tw .md rarl'I\' 111 the ,olon (6) S<1matosta1i n-14 1, rlw pr111t1pal 1<1rm rek•ast'd from tlw ,tom,Kh S0m.1t<1st,11m rde,hl'd fr (lm ,m;11l 11nt·,11n .il mut'osa ts prl dommanth st1111a111,tati 11·l~. "hneas 11111<mmucnsal small 1111c,1mal neur.tl structures It is pn• dnm111,mtly sl1ma111sta1111-H. As om• of clw rl'gul.11,,ry pepudt·s of the d1gesut·e trau. It h,1s ,I "1de ,·.mety o f b1ologic.1l act1u11, It h.1, ht'l'll ,hnwn ro rt·dun· 1nrt.·,1111.d mt1til1t~ t 7 ')). enll'ric hormonl' rt•lc<1sL' (lJ. IL'J. ,plandrnic blo(1dOcm 1111. and 111 h 1h1t sl'c rt·tton by tlw g,1s1m
.111tru m J ll) , pancrt·as (lJ) ,rn d tlw small ,llld l.1£1.!l' llltl ''i[ll1l'S( 1,,17) T ht.·,t· propl'rtll's of n;ltlVL' scHnato,l.1· tin ha\'l' rtsltlted 111 tts hdng cons1dt·red ,ts an .111t1d1arrhl·,il .1gent ,int:L' Jl.)7 \ wht·n Rra:cau and tolleagu,•, I I S) 1su· l.1ted, 'l'qlll'nccd .111d synthl',tZl'd tlw peptid e in,111 hm 11w lwpoth,1lamit t·x· trac 1. fhe pl'pttdl' ".1, 1111ttallv ll'rnwd gmwth horn1<11w 1ek.1st' mhih1t1nJ,? f,ll · tor tCiHRil'l h11t 1s no\\ l'lllllmPnh \,; m ,wn ,ls snma1os1;11111 FHlORAI-.. Clinically. nat1\·e ,omacosratin has heL'n most effective as an anudiarrheal 111 hormonally mediated secremry diarrheas. including those produced by rumours secreting vasoact1vc inresnn;il pept1JL' !VIPoma) ( 19). 5-hydroxytryp[()phan (carcino1d syndrome) (20-11). g:1smn (Zollmgt'r-Ellison syndrome) and calct ton1n l mewst:1t1c islet cell carcinoma) 124) In non hormonally mediated diarrhea , howc\'er, it has heen less dfenivt' fmlmg to alter diarrhea mducL'd h\ cholera toxin ( 15) Although nauve ,om.nosmun ha, hccn sho\\'n m reduce smol Olttput 111 a pancnt with short bowel syndrome. this may han' oc.:urrcd because M)m,1tostat111 ,upprcs,cd the clevatl'd hlood levels ot glu cagon. gastromrcsunal polypeptide and pancreatic polypepmk (16) Unforrun::1tcly, 1he short h1olog1cal half-life ( ! to 3 mm,) and limned srabil1ty of n:lll\'e sommo,wrin nL'Ces,natt' it~ use via connnuous parenteral mfw,ion .ind thus limit its therapeuuc usl'f ulnes, Recently, an ocmpcptidc long .irnng somatost:uin anal1,guc. SMS 2L"'I t>95. (Sandostatin; Sando: In cl has hL'en synrhcs1:cd fr..,m thL' b1olog1cally act1n' pharmacophone (Figure 11(27) Begin nmg \\'ith the 1solnnon of nat1\·e ,omam statm-Hand the kno\\'IL'dgc 1)1 the mini ma! fragment nt't'ded for h 1ological acuon, scrvernl long actmg somaro,tatln annlogues hnve bt 'l'n ,vnd1l',i:ed ( 2~) . although the most l'ffoct1\·e rL This annlogue conrn111s [)-phenylalanine at one L'nd nnd an alcohol denva tiw of threo111nc at the other. making it res1stanr to en:ymauc dL'grada11011 ThL' substituuon of P-tryptciphan for L ·tryp tophan in po,1t1on t{ furth~·r reduce, deg radation and L'nhances the long ,Kting NATIVE SOMATO STATIN H 2 N -i ALA j-GLY -CYS -LYS effect This agL'nt has heen shown to he more potent and longer acting than native somatoscann and can he adm1111Stered subcutaneously (27) (28) (29) In \'llro, SMS 201-995 has an anusccretory cfkct on intestmal fluiJ and dec· tmlytl' trnm,pnrt sim ilar to that of native ,omatosrann ( 29) SMS 201-995 mhibns elcctrnge111c anion secretion and stimulates neutral sodium and chloride absorption and thus has a porenual for a potent anud1arrheal agent (29 ( H-,5) In \1·atL'ry d1arrhc;i, hypokalc1111a , achlnrhydn;i ,yndrnme. vasoacuve 111tes-tinal pcpude and 11, homologue. peprndmL' hisudme 1sokuc11w, arl' markl·Jly reduced with the l' hangL' in nt't intc,unal secreuon to net absorption and a significant rL'duction 111 "tool weight .ind frequency, with resultant 111dept'ndl·nce from mtravenou, fluid requ1rcml'nts ( H. ,6-41 ) . In only one 11f these casL',ol Vlf>omas did a decren,c 111 d1.irrhe:1 continue dL'spice increa,cd va,oacnw 111tt·,-t111;il pcpude kvel, 111 the face n( further metastases ( >6)
In the carcinrnd syndrome, ,omatosta· un analogt.:c has ,1gn1hcantly redlKL'd hmh flush ing, unstable angina and diarrhea hy rL'duc111g nrculnung ,l'rotonin and kin1n ll'\els ( > 1.42-44) During mL'ta,tasnc medullnry carcm11ma ot thl' thyr01J, somat1btatm analogue allc\·t,Ht·d the symptoms of nu,hing and diarrhea associated w1th cle\·.ttcd calrnon111 le\' eb hut did not altL'r the course of the disease I 15.44.45) Somatrn,tatin analogue has also pro· duced nn euglyccmic scatt' in insulmoma and glucagonoma syndromes I>> I In iht glucagonoma syndrome. somatostaun analogue therapy ha, bet'n used to amc liorate the migrawry nccrolyuc dcrmauus () )) In summary, somatostann anal1it:ue which can bl' adm111is1ered tn an outpanent on an mtcrmment h:i-,1,. ,, prming invaluable 111 patten ts with rare. ncu· rot..'ndocnne ,ecn'ting tumour, b} con· trolling the life thrcatcnmg dinrrh1.:a and vasomotor respOlbt's Furthermore, the p1,tcntial ex1'r.., for ir, u,e 11Hraopcr· an\'clv during ,urg1cal ma111pularion of 
Jm L-inJitophan ar />oSlll<Jn H rcJ1;ce., cnunw11c JeRrnJ<J11011 amount:, 11! biologtcally acrive pq:nides can he released following su rgical manipulation of the tumour The mechanism of acticm pf somatostatin analogue in controll111g symptoms of neurocndocrinc tumours has noc hl'L'n elucidated However. it appc;1rs m he a consequence of reduced circulati ng amine and peptide levels. Dia rrh ea w ith n o n e ndocr ine e ti ology: In pmients with diarrhL'cl not atrrihurable to neu rnend1,cnnc tumnun,, treat· mcnt resu lts wnh snmatostatin :i n alogue haw been less dramatic In diarrhea due co chol.:ra cntcroto;,,.in (46 ). ileosLOmi 147). l!lOamm,nory bowel disca:,c 14KI and d1ahcnc dia rrhea I unpublished observations), somatosmti n analogue has not bee n effective Nevertheless, the somacoscatin analogue has been described co con t rol severe diarrhen as a consequence of lll fa n t secretory diarrhea ( 49.
50). cr yprosporic.lia infec t ion in the acquired immune deficiency syn drome
(55-5 3). nonsccretory ileostomy d iarrhea ( 54.55) diabetic dia rrhea ( 34.56) and in 50";, of cnscs with idiopath ic secrcrory diarrhea ( 32). Since hormone levels were not m ·1su recl tn many of these reports, it is difficult to determine whether the effect of soma tostatin analogue was a con-:;eq ucnce of reduced hormonal ou t put or a dm.
•ct antidinrrheal action on the intestine. In nonnL'Lm 1endocnnc medwted d iarrhea. the effect 1 ,f somatmtat111 analogue appear, \';inahk and may relate tc, rhL' inahtl1ty tn achieve thcrapn1t1c drug levels at the l'nterorytc level G astroin testinal h e m orrhage: C,111-trol of bleed111g hy nauve ~orna to~rnt1n therapy h as hecn reported in hoth nonvaricc:il ,llld \'nnceal hcm1,rrhagcs 111 a ,m::i ll nu mhcr c,f ,tud ic, ( 5 7 ). Scud 1cs w examine the effect of somatoscatin analogue on gastromtestinal hemorrhage arL' even fewer and till' results arc contl1ct· ing In treatmL'nt of rdapslllg bleedmg pepuc uker, in ,1 patient wi th ZollingerEllison syndrome, it was found m he more potent than n ative somatostmin in reducing gastnc aCJd secretion and in reduci ng 1n rcs11nal mucosa! blondflow for n substan t ially longer period and resulted in cessation o(bleec.l1ng 1n e ight o ( IL' pauen ts ( 5K, 59 ) . S11mat0starm analogues demonstrated a lfose dependent effect 1111 till' mortaltry, incidence and intensi ty nf cystearnineinduced duodenal lesions 111 rnrs {60) In conrrast, ,<,matostmin analogue did 1101 dc.'monstratc splanchnic vasocc11btnc-ti vc effects in ,tncsthemcd pigs Llcspite adc.'quate scrum le\'els {61 J and inhihned naturally occuring vasopressin secretion during gastrointesrinal h rnwrrh nge (62) .
With the present da), effernvcnL'SS Ill safely ,uppressmg gastric nc1d production and w1th the adven t of tlwrapcunc endoscopy. it 1s unlikelv that sommosmun analogues will replnc<' existing therapy for gastrnintcstinal hemorrh age. P a ncreacic fi stu las: S0matostat111 :malogue, haYc hecn demonsrratcd tn p<l· tcnrly inhihit ex<1crine pancrearic seen'· Lion, b1carbon:nc, protein nnJ Ou1J 111 .1 dnsc dependen t fashion (6 n The treat· me1H of pancrc,1tic cutaneous fistulas \\ ith somntostatin analogues h;1s been rcpnned m nine patients (64-69 I In cnch of th ese cases. fistu la output \\'as cnn,istcncly red uced during somatostat1n an,1· logul' adm1n1strarinn Nevertheless, Ill 1)nly three of these patten ts \\'as it documL'ntcd that fistulas closL·d as a conscquenccof Mnnatostmin analogue.1dm1n -1,trarion Pa n erea tis: In a controlled. douhlchlind, multiccntn' trial. nat ive sc1ma111· ,tmin in the treatment cl acute 1>ancrc-;u1r1s dcmc,nstrarcd no nd\'antage in uther the cour,e of the disease or thL' 111orcal1ry (70) Recently, somatostatin an;.ilogucs h:1ve heen identified to h,\\ L' a cytoprotecti\ e effect on pancrcauc, bronchial and gastric epithelium 17 1 ). The mechanism leading to tbsue pro· tcction h:is nor been clarified. a lthc,ugh srnhili:ati\,n of cell membrane as well a, changes 111 amm11 acid sequence mav play a role Snmatostalln analogues c1dmin1stcred prior ro varic,us forms of experimental pancremitis hnve improved survl\·al. ckmonstrated improved hiswlogical hl.'a ling ,rnd reduced scrum levels of lipase and amylase ( 72-7+ ). Once again, the mccharnsm of this effect during pancrcntitis is unkno\\'n hu t may relate to 111hibit1on of pancreatic en:ymc sccrcuon . Recently. Conwny and colleagues 17 5) demonstrated in dogs th at som:nostatln analogu e prod uces ;1 prnmpc a nd Somatostatin analogue: Therapeutic potential sustained dccrensc in pancrcauc bloodnow Wi th ou t altCnlllOn 111 systemic hcmodynamics Sommostaun an.1logucs do nm presently have a role in the 1rea1mc'n1 of acutl' pancreati tis outsidc the clinical research centre. Neverthcless. their role in preventing pancrea t ius following endoscopic or surgical manipula11on of the pancreas remnins to he deter111111cd S h o r t b owe l sy ndro m e: A lthoul,!h Dharmsathaphorn ,ind colk:11,!UL''> 17()) demonstrated. as ea r ly as 1982. that narive somawsrntin decreases diarrhea in patients with short bowel ,yndrome. only a sing le case report of a child exist, to demonstrate the use of long nctlllg ,omatostatin in concrollmg ilenl output ns a consequence of the short bowel syndrome (77) Dump ing sy ndr o m e : S ince M)m;1to-stat1n inh ibits vasonctive pcptidcs and amines and prevents massive Ouid secrenon into the intestinal lumen. the poten · rial therapeu uc effect fo r the treatment oi dumpmg sy ndrome exists.
The effect of sommostatin analogue Ill I() patients with retractable early clump111g and seven patients with severe late dumpini,: has been examined (78.79). ln hoth carly and late dumpers, sornatosta· tin anal11guc improved symptoms and hrearh hydrogen excretion , indicating ,lowing oi gastrointestinal motility. U nf<)rtunacc ly, the J1mimhing rate of gasinc surgery for peptic ulcer disease may m,1ke a large, double-blmd study to c'xaminc the effect of ,omarostatin analogue on gnstric dumping difficult to carry o u t ACK NOWLEDGEM ENT S: Dr l·eJorak 1, a rc'c1r1ent of che Alberta Hernagc foun· Jation fo r Medica l Research cl1111cal mvc,ti· g,llor',htp Th 1, work 1~ supponcd hy i1 grant from the Alberta Hc'nwgc Foundat1lln for Mc'd1C,1l Re,carch The author expresses his ,1ncere appreciarion for che expert st·cretar- 
